Advanced in Psoriasis

Dr. Alison Ehrlich

Dermatology
5530 Wisconsin Ave Ste 530, 
Chevy Chase, MD 
Advanced in Psoriasis
5530 Wisconsin Ave Ste 530, 
Chevy Chase, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alison Ehrlich is a Dermatologist in Chevy Chase, Maryland. Dr. Ehrlich is rated as an Advanced provider by MediFind in the treatment of Psoriasis. Her top areas of expertise are Contact Dermatitis, Juvenile Dermatomyositis, Dermatomyositis, and Psoriasis.

Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles in the study of Psoriasis.

Specialties
Dermatology
Licenses
Procedural Dermatology in MD
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

5530 Wisconsin Ave Ste 530, Chevy Chase, MD 20815

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: August 03, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Drug
Study Drug: EB01 Cream
Study Phase: Phase 2
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
An Open-label, Single-Arm Pilot Study Investigating the Efficacy and Safety of Apremilast for the Treatment of Moderate to Severe Chronic Hand Dermatitis
An Open-label, Single-Arm Pilot Study Investigating the Efficacy and Safety of Apremilast for the Treatment of Moderate to Severe Chronic Hand Dermatitis
Enrollment Status: Withdrawn
Publish Date: January 11, 2023
Intervention Type: Drug
Study Phase: Phase 4
Photodynamic Therapy for Papulopustular Rosacea
Photodynamic Therapy for Papulopustular Rosacea
Enrollment Status: Completed
Publish Date: December 29, 2022
Intervention Type: Drug, Other, Device
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Other, Biological
Study Drugs: Lebrikizumab, Topical Corticosteroid
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 6 Less Clinical Trials

47 Total Publications

Nutritional Supplements and Cosmetic Formulations: A Review of Emerging Allergens.
Nutritional Supplements and Cosmetic Formulations: A Review of Emerging Allergens.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: October 16, 2025
Similar Doctors
Distinguished in Psoriasis
Dr. Lawrence J. Green
Dermatology
Distinguished in Psoriasis
Dr. Lawrence J. Green
Dermatology

Privia Medical Group, LLC

9470 Annapolis Rd, Suite 309, 
Lanham, MD 
 (12.9 miles away)
202-832-1800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lawrence Green is a Dermatologist in Lanham, Maryland. Dr. Green is rated as a Distinguished provider by MediFind in the treatment of Psoriasis. His top areas of expertise are Acne, Plaque Psoriasis, Psoriasis, and Rosacea. Dr. Green is currently accepting new patients.

Distinguished in Psoriasis
Dr. Benjamin N. Lockshin
Dermatology
Distinguished in Psoriasis
Dr. Benjamin N. Lockshin
Dermatology

Derm Associates LLC

10313 Georgia Ave, Suite 309, 
Silver Spring, MD 
 (3.4 miles away)
301-681-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Benjamin Lockshin is a Dermatologist in Silver Spring, Maryland. Dr. Lockshin is rated as a Distinguished provider by MediFind in the treatment of Psoriasis. His top areas of expertise are Atopic Dermatitis, Psoriasis, Plaque Psoriasis, and Syringoma. Dr. Lockshin is currently accepting new patients.

Distinguished in Psoriasis
Dr. Ronald B. Prussick
Dermatology
Distinguished in Psoriasis
Dr. Ronald B. Prussick
Dermatology

Anne Arundel Dermatology PA

7101 Guilford Dr, Suite 105, 
Frederick, MD 
 (33.7 miles away)
855-314-1425
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Ronald Prussick is a Dermatologist in Frederick, Maryland. Dr. Prussick is rated as a Distinguished provider by MediFind in the treatment of Psoriasis. His top areas of expertise are Psoriasis, Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus. Dr. Prussick is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ehrlich's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile